World-First Lung Cancer Vaccine Trials Launched Across Seven Countries 🌍

News & Articles
,
1

Summary:

  1. Groundbreaking Vaccine
    The world’s first mRNA lung cancer vaccine, BNT116 by BioNTech, is now being tested in patients. This vaccine aims to teach the immune system to target and destroy cancer cells, and prevent their return.

  2. Global Trial
    The phase 1 clinical trial has started at 34 research sites across seven countries, including the UK, US, Germany, Hungary, Poland, Spain, and Turkey, involving about 130 patients with various stages of non-small cell lung cancer (NSCLC).

  3. Innovative Approach
    The vaccine uses mRNA technology, similar to Covid-19 vaccines, to train the immune system to recognize and attack NSCLC cells while sparing healthy cells, offering a new alternative to traditional chemotherapy.

Read more at: The Guardian

1 Like